PD Dr. rer. nat. Andreas Roos
Research Coordinator - Dep. of Neuropediatrics, University of Duisburg-Essen 🡵
Adjunct Professor - University of Ottawa 🡵
![[NMD-GPS]](/.cm4all/uproc.php/0/Bilder/.Logo_NMD-GPS_150px.jpg/picture-1200?_=1715988ba28 "[NMD-GPS]"){kind=logo}
GENOMIC AND PROTEOMIC SIGNATURES AS A GPS IN NEUROMUSCULAR DISEASES
Welcome dear visitor
As senior scientist I am working in the field of translational medicine with a main focus on neurodegenerative and neuromuscular disorders.
In order to understand the etiology of these diseases and to obtain a full picture, my work focusses on the identification of the genetic cause as well as on the discovery of the related pathophysiological consequences. For the latter purpose, various biochemical techniques including different proteomic approaches are applied by making use of in vitro and in vivo models as well as of patient-derived material.
I'd like to invite you to discover my field activity and related projects.
Best regards
Andreas Roos
News |  |
20.02.2021
Recently accepted paper
Dysregulation of GSK3β-target proteins in skin fibroblasts of Myotonic Dystrophy type 1 (DM1) patients. Journal of Neuromuscular Diseases. ~ Grande V, Hathazi D, O´Connor E, Schara-Schmidt U, Hentschel... mehr
20.02.2021
Recently accepted paper
INPP5K- and SIL1-related disorders: identification of a common molecular pathway toward a treatment strategy. Brain. ~ Hathazi D, Cox D, D'Amico A, Tasca G, Charlton R, Carlier RY, Zahedi R, Kollipara... mehr
20.02.2021
Recently accepted paper
Regulatory function of sympathetic innervation on the endo/lysosomal trafficking of acetylcholine receptor. Frontiers in Physiology. ~ Straka T, Schröder C, Roos A, Kollipara L, Sickmann A, Williams... mehr
20.02.2021
Recently accepted paper
Exome reanalysis and proteomic profiling identified TRIP4 as a novel cause of cerebellar hypoplasia and spinal muscular atrophy (PCH1). European Journal of Human Genetics. ~ Töpf A, Pyle A, Griffin H,... mehr